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P1
Large scale three-dimensional cartilage tissue engineering using 
adult bone marrow stem cells from OA patients
S. Mistry1, M. Pabbruwe2, A.P. Hollander3;
1Academic Rheumatology, University of Bristol, Bristol, Bristol, 
United Kingdom, 2Clinical Science At North Bristol, University 
of Bristol Academic Rheumatology, Bristol, United Kingdom, 
3Department Of Clinical Science At North Bristol, University of 
Bristol Academic Rheumatology, Bristol, United Kingdom
Purpose: We have previously shown the ability of adult BMSCs to 
engineer mature cartilage on 4 mm PGA scaffolds. However there 
is need to increase the construct size in order to successfully treat 
patients with large cartilage lesions. The aim of this study was to 
investigate scaling up our current tissue engineering protocol by 
increasing the scaffold size to 8mm diameter and comparing natural 
collagen (Chondrogide®) and synthetic (PGA) scaffolds. 
Methods and Materials: BMSCs were expanded using growth 
medium with cytokines to maintain stem cell growth and 
chondrogenic potential. Cells were seeded onto Fibronectin coated 
(8mm) PGA and Chondrogide® scaffolds and cultured for 35 days 
in TGF-ȕ3 supplemented differentiation medium. Samples were 
biochemically and immunohistochemically analysed for GAG, type I 
and type II collagen. 
Results: 8mm PGA constructs (n=5) showed synthesis of GAG (50 
% mean dry weight), type II (9.4 %) and type I collagen (2.1 %). 
Chondrogide® (n=5) also showed GAG (30 %), type II (17 %) and type 
I collagen (2.66 %). 4mm PGA scaffolds (n=20) showed synthesis 
of GAG (35 %), type II (17 %) and type I collagen (1.64 %). There 
XFSFOPTJHOJ¾DBOUEJGGFSFODFT JONBUSJYDPNQPTJUJPOCFUXFFOUIF
various scaffolds. All constructs stained positive for GAG, type I and 
II collagen. 
Conclusions: We have successfully engineered cartilage constructs 
using stem cells from OA patients. Our tissue engineering protocol 
can be scaled up to larger sizes and applied to natural and synthetic 
scaffolds to deliver high quality implants using stem cells from OA 
patients as a cell source. 
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Injectable mesenchymal stem cell-hyaluronic acid(MSC-HA) 
therapy for cartilage defects- preliminary results
J.H. Hui1, E.H. Lee2, K.B.L. Lee3;
1Department Of Orthopaedic Surgery, National Universtiy 
of Singapore, Singapore, Singapore, 2Orthopaedic Surgery 
Department, Tissue Engineering Program, National University 
Singapore, Singapore, Singapore, 3Orthopaedic Surgery, National 
University Hospital, Singapore, Singapore
Purpose: Current techniques in biological resurfacing of cartilage 
defects require an open arthrotomy or arthroscopy and involve the 
direct transplantation of isolated cells and or scaffolds, or whole 
tissue grafts with chondrogenic potential onto the cartilage defect. 
Our study investigates the effect of direct intra-articular injection of 
mesenchymal stem cells (MSCs) suspended in hyaluronic acid (HA) 
as an alternative to methods currently available. 
Methods and Materials: Thirty patients with cartilage defects in 
the medial femoral condyle were selected for the study. Autologous 
mesenchymal stem cells from the iliac crest marrow were harvested 
under local anaesthesia and cultured in GMP laboratory. 2 weeks 
later, a microfracture was performed, and BMSCs suspended in 2ml 
of Synvisc® (Hylan G-F 20) were injected intra-articularly 10 days later. 
This was followed by 2 more injections of Synvisc® (HA) at weekly 
intervals. The controls were knees treated only with microfractures. 
Pre- and postoperative SF-36 and IKDC subjective knee scores were 
analyzed. Post-operative MRIs were performed in all knees at 6 
months post-operation. 
Results: There were no complications such as infections during 
UIF NFBO GPMMPXVQ QFSJPE PG  NPOUIT 5IFSF XFSF TJHOJ¾DBOU
improvements in the SF-36 domains for Physical Function, Bodily 
Pain, Physical and and IKDC score. MRIs performed after surgery 
documented cartilage regeneration with some sub-chondral 
reconstitution of defects. 
Conclusions: The use of intra-articular injections of mesenchymal 
stem cells suspended in HA is a viable option for treating large 
cartilage defects. This injectable method has good prelimnary results 
but requires long term evaluation. 
P3
Prospective evaluation of osteochondral defects in the knee 
treated with biodegradable scaffolds
P.A. Davidson1, D.W. Rivenburgh2;
1Ortho, Tampa Bay Orthopedic Specialists, Pinellas Park, United 
States of America, 2Orthopaedics, Tampa Bay Orthopaedic 
Specialists, Pinellas Park, FL, United States of America
Purpose: This study reports on the usage of a biodegradable 
polymeric scaffold to treat symptomatic full thickness chondral and 
osteochondral defects of the knee. 
Methods and Materials: In a prospective manner, following IRB 
approval, 47 sequential patients were treated over 2 years. The 
cylindrical orthobiologic scaffolds were surgically implanted 
to restore a smooth surface contour. Concurrent procedures 
included: 8 ligament reconstructions, 15 meniscal treatments, 
3 patella realignments, and one hardware removal. All patients 
underwent preoperative and postoperative clinical and radiographic 
evaluation and were systematically followed at regular intervals. 
Postoperatively, all patients were maintained touch down weight 
bearing with crutches for 6 weeks, allowing immediate full range of 
motion. 
Results: Mean follow up was 20 months (range 8 to 34 months). 
Mean age was 42 years. Mean number of grafts was 1.9 (range 1-7, 
total 82). Mean area grafted was 1.4 cm² (range 0.4-3.1 cm²). SF-36 
Physical mean score improved from 36 pre-treatment to 47 post-
surgery. IKDC mean score improved from 32 to 64. The Lysholm 
mean score improved from 39 to 79. There was no radiographic 
evidence of bone lysis or evident complications. Two patients were 
deemed failures, and went on to arthroplasty for what were felt to be 
concurrent, unrelated pathologies. There were no other failures, and 
OPDPNQMJDBUJPOTSFMBUFEUPUIFTDBGGPMETXFSFJEFOUJ¾FE
Conclusions: "MM QBUJFOUT FYDFQU UXP TIPXFE TJHOJ¾DBOU
improvements post-treatment as measured by each of the scoring 
JOTUSVNFOUT 5IJT UFDIOPMPHZ TIPXT TJHOJ¾DBOU QSPNJTF JO UIF
clinical management of relatively small chondral and osteochondral 
defects. 
P4
All-inside suture techniques have advantages over inside-out 
TVUVSFTGPS$PMMBHFO.FOJTDVT*NQMBOU	$.*
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D.G. Holsten1, W.G. Rodkey2, K.K. Briggs3, R. Schwabke1;
1Arthroscopy, Katholisches Klinikum Bruderhaus St. Josef Koblenz, 
Koblenz, Germany, 2Basic Science, Steadman Hawkins Foundation, 
Vail, CO, United States of America, 3Clinical Research, Steadman 
Hawkins Research Foundation, Vail, CO, United States of America
Purpose: 5SBEJUJPOBM¾YBUJPOPG$PMMBHFO.FOJTDVT*NQMBOUT	$.*
UP
meniscus remnants has been inside-out sutures. We developed all-
inside suturing of CMI using FasT-Fix (Smith&Nephew) to minimize 
inherent limitations. This study compared inside-out suture results 
with all-inside results. 
Methods and Materials: Six patients underwent medial CMI 
implantation with inside-out sutures. Twenty-six patients had medial 
CMI implanted using an all-inside technique. We compared meniscus 
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operative time, intraoperative complications, and complications 
over twelve postoperative weeks. Data were analyzed using an 
independent t-test. 
Results: Defect size and CMI length for inside-out patients averaged 
45 mm and 50 mm, and for all-inside patients 46 mm (p=0.92) and 
48 mm (p=0.58), respectively. Average total operative time of 135 
NJOVUFTGPSJOTJEFPVUQBUJFOUTEFDSFBTFETJHOJ¾DBOUMZUPNJOVUFT
for all-inside patients (p=0.0001). On average, 8.5 sutures were 
used for inside-out technique, and 5.2 FasT-Fix devices were used 
GPSBMMJOTJEF	Q
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operative time and sutures (r=0.55; p=0.001). There was one 
effusion and one intraarticular infection that required reoperation in 
inside-out group. In FasT-Fix group, one CMI was damaged, requiring 
a second CMI, and there was one effusion at 10 weeks that required 
arthrocentesis twice. No late or persistent complications were 
observed. 
Conclusions: All-inside FasT-Fix to secure CMI to the host meniscus 
SJNTJHOJ¾DBOUMZSFEVDFEUPUBMPQFSBUJWFUJNFDPNQBSFEUPJOTJEFPVU
sutures for equal lesions and similar CMI length. Patient morbidity 
XBTSFEVDFEUIF¾STUUXFMWFQPTUPQFSBUJWFXFFLT/PTFSJPVTDMJOJDBM
complications were encountered using all-inside FasT-Fix. 
